
Mathieu Martin
Gestionnaire de fonds spécialisé en microcaps (Rivemont Micro-Cap) avec une expérience d'investissement concentré et une stratégie axée sur la recherche approfondie et la prise de positions significatives.
Top 3 podcasts with Mathieu Martin
Ranked by the Snipd community

Jan 14, 2026 • 1h 1min
Penny Stock : Danger ou opportunité ? | Investi (Ép. 28)
Mathieu Martin, gestionnaire de fonds chez Rivemont Micro-Cap, et Philippe Bergeron, associé chez Barricad Capital, explorent le monde des penny stocks. Ils partagent comment leur passé au poker a façonné leur approche d'investissement. La conversation aborde la distinction entre pari et investissement réfléchi, l'importance d'une recherche approfondie, et les défis de liquidité dans le secteur micro-cap. Ils discutent aussi des signaux d'alerte à surveiller et des stratégies pour bénéficier d'opportunités inexploitées.

Jun 26, 2025 • 52min
The 2025 Turnaround in Canadian Cannabis with Mathieu Martin, Portfolio Manager at Rivemont MicroCap Fund
Mathieu Martin, Portfolio Manager at Rivemont MicroCap Fund, dives into the evolving landscape of Canadian cannabis, spotlighting the emergence of profitable operators amidst a challenging market. He discusses why traditional investors are missing opportunities by overlooking cash flow over flashy revenue. Mathieu highlights standout companies like High Tide and the significance of regulatory changes. With a fresh perspective, he explores international markets and brand differentiation, urging listeners to reassess the cannabis sector.

Jul 25, 2024 • 1h 6min
The Investment Case for Canadian MicroCaps with Mathieu Martin, Portfolio Manager of the Rivemont MicroCap Fund
Mathieu Martin is a microcap specialist and Portfolio Manager of the Rivemont MicroCap Fund, with a keen eye on Canadian stocks. He shares how his love for microcaps ignited and discusses the inefficiencies he observes in this market. U.S. investors often overlook these opportunities, but Mathieu highlights the current undervaluation of Canadian microcaps, especially in sectors like technology and healthcare. He also reflects on the lessons learned from a tough year in 2022 and emphasizes the importance of disciplined research and risk management in navigating this unique investment landscape.


